Literature DB >> 10217528

A non-pungent triprenyl phenol of fungal origin, scutigeral, stimulates rat dorsal root ganglion neurons via interaction at vanilloid receptors.

A Szallasi1, T Bíró, T Szabó, S Modarres, M Petersen, A Klusch, P M Blumberg, J E Krause, O Sterner.   

Abstract

1. A [3H]-resiniferatoxin (RTX) binding assay utilizing rat spinal cord membranes was employed to identify novel vanilloids in a collection of natural products of fungal origin. Of the five active compounds found (scutigeral, acetyl-scutigeral, ovinal, neogrifolin, and methyl-neogrifolin), scutigeral (Ki=19 microM), isolated from the edible mushroom Albatrellus ovinus, was selected for further characterization. 2. Scutigeral induced a dose-dependent 45Ca uptake by rat dorsal root ganglion neurons with an EC50 of 1.6 microM, which was fully inhibited by the competitive vanilloid receptor antagonist capsazepine (IC50=5.2 microM). 3. [3H]-RTX binding isotherms were shifted by scutigeral (10-80 microM) in a competitive manner. The Schild plot of the data had a slope of 0.8 and gave an apparent Kd estimate for scutigeral of 32 microM. 4. Although in the above assays scutigeral mimicked capsaicin, it was not pungent on the human tongue up to a dose of 100 nmol per tongue, nor did it provoke protective wiping movements in the rat (up to 100 microM) upon intraocular instillation. 5. In accord with being non-pungent, scutigeral (5 microM) did not elicit a measurable inward current in isolated rat dorsal root ganglion neurons under voltage-clamp conditions. It did, however, reduce the proportion of neurons (from 61 to 15%) that responded to a subsequent capsaicin (1 microM) challenge. In these neurons, scutigeral both delayed (from 27 to 72 s) and diminished (from 5.0 to 1.9 nA) the maximal current evoked by capsaicin. 6. In conclusion, scutigeral and its congeners form a new chemical class of vanilloids, the triprenyl phenols. Scutigeral promises to be a novel chemical lead for the development of orally active, non-pungent vanilloids.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10217528      PMCID: PMC1565912          DOI: 10.1038/sj.bjp.0702440

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  44 in total

1.  Pain and inflammation induced by nicotine, acetylcholine and structurally related compounds and their prevention by desensitizing agents.

Authors:  N JANCSO; A JANCSO-GABOR; I TAKATS
Journal:  Acta Physiol Acad Sci Hung       Date:  1961

2.  Sensory effects of capsaicin congeners I. Relationship between chemical structure and pain-producing potency of pungent agents.

Authors:  J Szolcsányi; A Jancsó-Gábor
Journal:  Arzneimittelforschung       Date:  1975

3.  The cloned capsaicin receptor integrates multiple pain-producing stimuli.

Authors:  M Tominaga; M J Caterina; A B Malmberg; T A Rosen; H Gilbert; K Skinner; B E Raumann; A I Basbaum; D Julius
Journal:  Neuron       Date:  1998-09       Impact factor: 17.173

Review 4.  Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide.

Authors:  J M Lundberg
Journal:  Pharmacol Rev       Date:  1996-03       Impact factor: 25.468

5.  Insect antifeedant terpenes, hot-tasting to humans.

Authors:  I Kubo; I Ganjian
Journal:  Experientia       Date:  1981-10-15

Review 6.  Sensory neuron-specific actions of capsaicin: mechanisms and applications.

Authors:  S Bevan; J Szolcsányi
Journal:  Trends Pharmacol Sci       Date:  1990-08       Impact factor: 14.819

Review 7.  Vanilloid receptors: new insights enhance potential as a therapeutic target.

Authors:  A Szallasi; P M Blumberg
Journal:  Pain       Date:  1996-12       Impact factor: 6.961

8.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

9.  The antinociceptive effect and pharmacokinetics of olvanil following oral and subcutaneous dosing in the mouse.

Authors:  W K Sietsema; E F Berman; R W Farmer; C S Maddin
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

10.  Urodynamic effects of intravesical resiniferatoxin in humans: preliminary results in stable and unstable detrusor.

Authors:  M Lazzeri; P Beneforti; D Turini
Journal:  J Urol       Date:  1997-12       Impact factor: 7.450

View more
  5 in total

1.  Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide.

Authors:  Theodore J Price; Amol Patwardhan; Armen N Akopian; Kenneth M Hargreaves; Christopher M Flores
Journal:  Br J Pharmacol       Date:  2004-03-08       Impact factor: 8.739

2.  ThermoTRP channels in nociceptors: taking a lead from capsaicin receptor TRPV1.

Authors:  Sravan Mandadi; Basil D Roufogalis
Journal:  Curr Neuropharmacol       Date:  2008-03       Impact factor: 7.363

3.  Effect of ricinoleic acid in acute and subchronic experimental models of inflammation.

Authors:  C Vieira; S Evangelista; R Cirillo; A Lippi; C A Maggi; S Manzini
Journal:  Mediators Inflamm       Date:  2000       Impact factor: 4.711

4.  The pharmacological potential of mushrooms.

Authors:  Ulrike Lindequist; Timo H J Niedermeyer; Wolf-Dieter Jülich
Journal:  Evid Based Complement Alternat Med       Date:  2005-09       Impact factor: 2.629

5.  Next-generation sequencing of the human TRPV1 gene and the regulating co-players LTB4R and LTB4R2 based on a custom AmpliSeq™ panel.

Authors:  Dario Kringel; Marco Sisignano; Sebastian Zinn; Jörn Lötsch
Journal:  PLoS One       Date:  2017-06-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.